Elektrofi
Alex Stankiewicz, Ph.D., currently serves as the Associate Director of Business Development & Alliance Management at Elektrofi, leading efforts in identifying and negotiating partnerships with biotech and major pharmaceutical companies. Prior to this role, Alex worked at Biogen as a Senior Manager in Corporate Strategy & Disease Area Portfolio Innovation, focusing on commercial due diligence for in-licensing and M&A opportunities. With extensive experience as a Senior Consultant at TRINITY, Alex supported biopharma clients in executing business development transactions across various therapeutic areas. Academic contributions include a postdoctoral research position at the University of Connecticut, investigating pathological aging and neurogenesis, along with co-founding ClockCoach Inc., a digital health company. Alex earned a Ph.D. in Anatomy and Neurobiology from Boston University School of Medicine, where research specialized in adult neurogenesis in relation to external factors like sleep and diet.
This person is not in any teams
This person is not in any offices
Elektrofi
1 followers
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.